Induction therapy for active lupus nephritis:: mycophenolate mofetil versus cyclophosphamide -: Commentary

被引:10
|
作者
Burchardi, Christian [1 ]
Schloendorff, Detlef [1 ]
机构
[1] Univ Munich, Med Poliklin, D-80336 Munich, Germany
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2006年 / 2卷 / 06期
关键词
D O I
10.1038/ncpneph0184
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:314 / 315
页数:2
相关论文
共 50 条
  • [21] Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide
    Baños, I
    Yebra, M
    Fernández, J
    Cajal, YSR
    [J]. MEDICINA CLINICA, 2003, 121 (04): : 158 - 158
  • [22] Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis
    Killen, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07): : 764 - 765
  • [23] Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
    Sedhain, Arun
    Hada, Rajani
    Agrawal, Rajendra K.
    Bhattarai, Gandhi R.
    Baral, Anil
    [J]. BMC NEPHROLOGY, 2018, 19
  • [24] Cyclophosphamide versus mycophenolate mofetil for initial treatment of lupus nephritis Reply
    Radhakrishnan, Jai
    Cattran, Daniel
    [J]. KIDNEY INTERNATIONAL, 2013, 83 (05) : 969 - 969
  • [25] Comparison of Mycophenolate Mofetil and Intravenous Cyclophosphamide As Induction Therapy in Korean Patients with Lupus Nephritis.
    Park, Dong-Jin
    Lee, Kyung-Eun
    Kim, Tae-Jong
    Park, Yong-Wook
    Lee, Shin-Seok
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S952 - S953
  • [26] Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
    Arun Sedhain
    Rajani Hada
    Rajendra K. Agrawal
    Gandhi R. Bhattarai
    Anil Baral
    [J]. BMC Nephrology, 19
  • [27] Mycophenolate Mofetil versus Azathioprine in the Maintenance Therapy of Lupus Nephritis
    Sahin, Gulizar Manga
    Sahin, Sevgi
    Kiziltas, Safak
    Masatlioglu, Seval
    Oguz, Fusun
    Ergin, Hulya
    [J]. RENAL FAILURE, 2008, 30 (09) : 865 - 869
  • [28] Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis Systematic Review and Meta-Analysis
    Kamanamool, Nanticha
    McEvoy, Mark
    Attia, John
    Ingsathit, Atiporn
    Ngamjanyaporn, Pintip
    Thakkinstian, Ammarin
    [J]. MEDICINE, 2010, 89 (04) : 227 - 235
  • [29] Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis A Meta-Analysis of Randomized Controlled Trials
    Liu, Lin-lin
    Jiang, Yi
    Wang, Li-ning
    Yao, Li
    Li, Zi-long
    [J]. DRUGS, 2012, 72 (11) : 1521 - 1533
  • [30] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    Eid M. El-Shafey
    Said H. Abdou
    Mohamed M. Shareef
    [J]. Clinical and Experimental Nephrology, 2010, 14 : 214 - 221